OR4A41P

Across TCGA pan-cancer cohorts, OR4A41P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR4A41P data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher OR4A41P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4A41P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

CESC, KIRC, and PAAD are the cancer types where OR4A41P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.047	0.875	<.001	72	view →
KIRC	DFS	Tertile	IV	0.107	0.650	<.001	54	view →
PAAD	DFS	Tertile	All	0.118	0.468	.012	45	view →
HNSC	OS	Tertile	All	0.922	0.348	.017	45	view →
UCEC	OS	Tertile	All	0.842	0.929	.007	36	view →
SARC	OS	Tertile	All	0.189	0.747	<.001	36	view →
SKCM	DFS	Tertile	All	0.192	0.757	.022	27	view →
LAML	DFS	Tertile	All	0.046	0.588	<.001	18	view →
ESCA	OS	Tertile	All	0.418	0.708	.034	9	view →
STAD	OS	Tertile	All	0.341	0.576	.047	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR4A41P–CESC (OS)

Open the CESC breakdown →